Hims & Hers (HIMS) is up 12.0%, or $2.67 to $24.83.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Unusually active option classes on open March 10th
- Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
- Notable open interest changes for March 10th
- Novo Nordisk’s Hims deal helps with commercial headwind, says BMO Capital
- Re-Rating Hims & Hers: Novo Nordisk Partnership De-Risks GLP-1 Exposure and Supports Further Multiple Expansion